CCR1 and ovarian carcinoma: CCL23 is the natural ligand for the cognate receptor, CCR1, which promotes tumor-supportive processes such as the recruitment of myeloid cells, endothelial cell migration, angiogenesis, and T-cell exhaustion in ovarian cancer [12,13,14].